NEW YORK, Dec. 14, 2017 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm that invests in middle-market specialty industrials and healthcare companies, announced today the promotion of Gene Gorbach, Roy Seroussi, and Brian Orkin to Investment Partner. In addition, Yoonmo Yang has been promoted to Vice President.
"We are very pleased to recognize these individuals and their contributions to the firm," said Arsenal's co-founder and Partner Jeff Kovach. "At the core of Arsenal's success is a deep and talented team, and we remain committed to the continuous development of our professionals. Gene, Roy, and Brian each play important leadership roles within Arsenal, and we look forward to many more years of successful partnership with them."
Mr. Gorbach joined Arsenal in 2008 as a Senior Associate and currently serves on the boards of three healthcare companies: BioIVT, TractManager, and WCG. Mr. Seroussi joined Arsenal in 2008 as an Associate on the specialty industrials team and currently serves on the boards of Cyalume Technologies, Inhance Technologies, Elite Comfort Solutions, and Polymer Solutions Group. Brian Orkin joined Arsenal in 2010 and plays various business development and strategy roles on the specialty industrials team. Mr. Yang joined Arsenal in 2016 as a Senior Associate on the healthcare team.
Established in 2000, Arsenal Capital Partners is a leading private equity firm that specializes in investments in middle-market specialty industrials and healthcare companies. Since inception, Arsenal has raised institutional equity investment funds of approximately $3 billion. Arsenal invests in industry sectors in which the firm has significant prior knowledge and experience and seeks companies typically in the range of $100 - $500 million of initial enterprise value. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add.
Contact: Chris Tofalli
Chris Tofalli Public Relations, LLC
SOURCE Arsenal Capital Partners